31 related articles for article (PubMed ID: 23364605)
1. Atorvastatin-induced intracerebral hemorrhage is inhibited by berberine in zebrafish.
Liu XY; Chen B; Zhang R; Zhang MQ; Ma YY; Han Y; Jiang JD; Zhang JP
J Appl Toxicol; 2024 Apr; ():. PubMed ID: 38639436
[TBL] [Abstract][Full Text] [Related]
2. Stem cells alleviate OGD/R mediated stress response in PC12 cells following a co-culture: modulation of the apoptotic cascade through BDNF-TrkB signaling.
Kaur H; Sarmah D; Datta A; Borah A; Yavagal DR; Bhattacharya P
Cell Stress Chaperones; 2023 Nov; 28(6):1041-1051. PubMed ID: 36622548
[TBL] [Abstract][Full Text] [Related]
3. Higher cardiac vagal activity predicts lower peripheral resistance 6 years later in European but not African Americans.
Williams DP; Thayer JF; Halbert JD; Wang X; Kapuku G
Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H2058-H2065. PubMed ID: 33769914
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin ameliorates oxygen glucose deprivation/reoxygenation-induced pulmonary endothelial barrier dysfunction by restoring cell-cell junctions and actin cytoskeleton dynamics via the PI3K/Akt signaling pathway.
Han D; Sun J; Fan D; Zhang C; Du S; Zhang W
Am J Transl Res; 2020; 12(9):5586-5596. PubMed ID: 33042440
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological Modulation of Vagal Nerve Activity in Cardiovascular Diseases.
Liu L; Zhao M; Yu X; Zang W
Neurosci Bull; 2019 Feb; 35(1):156-166. PubMed ID: 30218283
[TBL] [Abstract][Full Text] [Related]
6. Choline ameliorates cardiovascular damage by improving vagal activity and inhibiting the inflammatory response in spontaneously hypertensive rats.
Liu L; Lu Y; Bi X; Xu M; Yu X; Xue R; He X; Zang W
Sci Rep; 2017 Feb; 7():42553. PubMed ID: 28225018
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholine ameliorates endoplasmic reticulum stress in endothelial cells after hypoxia/reoxygenation via M3 AChR-AMPK signaling.
Bi X; He X; Xu M; Zhao M; Yu X; Lu X; Zang W
Cell Cycle; 2015 Aug; 14(15):2461-72. PubMed ID: 26066647
[TBL] [Abstract][Full Text] [Related]
8. Activation of M3 cholinoceptors attenuates vascular injury after ischaemia/reperfusion by inhibiting the Ca2+/calmodulin-dependent protein kinase II pathway.
Lu XZ; Bi XY; He X; Zhao M; Xu M; Yu XJ; Zhao ZH; Zang WJ
Br J Pharmacol; 2015 Dec; 172(23):5619-33. PubMed ID: 25953628
[TBL] [Abstract][Full Text] [Related]
9. Novel strategies and underlying protective mechanisms of modulation of vagal activity in cardiovascular diseases.
He X; Zhao M; Bi X; Sun L; Yu X; Zhao M; Zang W
Br J Pharmacol; 2015 Dec; 172(23):5489-500. PubMed ID: 25378088
[TBL] [Abstract][Full Text] [Related]
10. Statins and ischaemia reperfusion injury: a molecular biological review.
Abdul Rahman MN; Chetter IC
Curr Vasc Pharmacol; 2010 Nov; 8(6):831-5. PubMed ID: 19485917
[TBL] [Abstract][Full Text] [Related]
11. Role of endothelial nitric oxide in cerebrovascular regulation.
Atochin DN; Huang PL
Curr Pharm Biotechnol; 2011 Sep; 12(9):1334-42. PubMed ID: 21235451
[TBL] [Abstract][Full Text] [Related]
12. Role of endothelial nitric oxide synthase and vagal activity in the endothelial protection of atorvastatin in ischemia/reperfusion injury.
Bi XY; He X; Zhao M; Yu XJ; Zang WJ
J Cardiovasc Pharmacol; 2013 May; 61(5):391-400. PubMed ID: 23364605
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction in rat mesenteric artery after regional cardiac ischaemia-reperfusion.
Zhao M; He X; Wier WG; Zhang HL; Zhao M; Yu XJ; Zang WJ
Exp Physiol; 2012 Jan; 97(1):70-9. PubMed ID: 21948192
[TBL] [Abstract][Full Text] [Related]
15. The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation.
Manickavasagam S; Ye Y; Lin Y; Perez-Polo RJ; Huang MH; Lui CY; Hughes MG; McAdoo DJ; Uretsky BF; Birnbaum Y
Cardiovasc Drugs Ther; 2007 Oct; 21(5):321-30. PubMed ID: 17620005
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
